# Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia

> **NCT02893423** · NA · TERMINATED · sponsor: **Maimonides Medical Center** · enrollment: 51 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT02893423
- **Lead sponsor:** Maimonides Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01-01
- **Primary completion:** 2016-09-30
- **Final completion:** 2016-09-30
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** A better study with a better drug was started and thus this study was terminated
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02893423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02893423, "Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02893423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*